Imminent FDA Approval of Addictive Ketamine for Depression Brings Back Echoes from the Opiate Epidemic - BioSpace

Imminent FDA Approval of Addictive Ketamine for Depression Brings Back Echoes from the Opiate Epidemic  BioSpaceWEST ORANGE, N.J., /PRNewswire/ -- FDA's approval of ketamine to address depression classified as 'treatment resistant' is a double-edged sword. "Ketamine ...